242 related articles for article (PubMed ID: 29467183)
1. The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
Plow EF; Wang Y; Simon DI
Blood; 2018 Apr; 131(17):1899-1902. PubMed ID: 29467183
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.
Wang Y; Gao H; Shi C; Erhardt PW; Pavlovsky A; A Soloviev D; Bledzka K; Ustinov V; Zhu L; Qin J; Munday AD; Lopez J; Plow E; Simon DI
Nat Commun; 2017 May; 8():15559. PubMed ID: 28555620
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet glycoprotein Ib and its antithrombotic potential.
Vanhoorelbeke K; Ulrichts H; Van de Walle G; Fontayne A; Deckmyn H
Curr Pharm Des; 2007; 13(26):2684-97. PubMed ID: 17897012
[TBL] [Abstract][Full Text] [Related]
4. Platelet GPIb complex as a target for anti-thrombotic drug development.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
[TBL] [Abstract][Full Text] [Related]
5. WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor.
Cao C; Yang Q; Xia X; Chen Z; Liu P; Wu X; Hu H; Ding Z; Li X
Thromb Res; 2024 Jun; 238():41-51. PubMed ID: 38669962
[TBL] [Abstract][Full Text] [Related]
6. Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.
Shen C; Mackeigan DT; Shoara AA; Xu R; Bhoria P; Karakas D; Ma W; Cerenzia E; Chen Z; Hoard B; Lin L; Lei X; Zhu G; Chen P; Johnson PE; Ni H
J Thromb Haemost; 2023 May; 21(5):1274-1288. PubMed ID: 36732162
[TBL] [Abstract][Full Text] [Related]
7. Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.
McFadyen JD; Peter K
Circ Res; 2017 Oct; 121(10):1133-1135. PubMed ID: 29074533
[No Abstract] [Full Text] [Related]
8. Future Antithrombotic Therapies in Cardiology.
Bäuml M; Hilgendorf I
Hamostaseologie; 2018 Nov; 38(4):236-239. PubMed ID: 30267387
[TBL] [Abstract][Full Text] [Related]
9. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for thrombosis: new targets and approaches.
Mackman N; Bergmeier W; Stouffer GA; Weitz JI
Nat Rev Drug Discov; 2020 May; 19(5):333-352. PubMed ID: 32132678
[TBL] [Abstract][Full Text] [Related]
11. Curcumin, hemostasis, thrombosis, and coagulation.
Keihanian F; Saeidinia A; Bagheri RK; Johnston TP; Sahebkar A
J Cell Physiol; 2018 Jun; 233(6):4497-4511. PubMed ID: 29052850
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy: new areas to understand efficacy and bleeding.
Wisler JW; Becker RC
Expert Opin Ther Targets; 2014 Dec; 18(12):1427-34. PubMed ID: 25347453
[TBL] [Abstract][Full Text] [Related]
13. Rational design of antithrombotic peptides to target the von Willebrand factor (vWf)--GPIb integrin interaction.
Munoz Cdel C; Campbell W; Constantinescu I; Gyongyossy-Issa MI
J Mol Model; 2008 Dec; 14(12):1191-202. PubMed ID: 18923852
[TBL] [Abstract][Full Text] [Related]
14. [An antithrombotic therapy from the viewpoint of hematology].
Asakura H
Brain Nerve; 2015 Jan; 67(1):83-91. PubMed ID: 25585437
[TBL] [Abstract][Full Text] [Related]
15. Current and future antiplatelet therapies: emphasis on preserving haemostasis.
McFadyen JD; Schaff M; Peter K
Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
17. [Anti-platelets without a bleeding risk: novel targets and strategies].
Schaff M; Gachet C; Mangin PH
Biol Aujourdhui; 2015; 209(3):211-28. PubMed ID: 26820829
[TBL] [Abstract][Full Text] [Related]
18. Targeting integrin and integrin signaling in treating thrombosis.
Estevez B; Shen B; Du X
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):24-9. PubMed ID: 25256236
[TBL] [Abstract][Full Text] [Related]
19. Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications.
Scridon A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361561
[TBL] [Abstract][Full Text] [Related]
20. The role of platelets in athero-thrombotic events.
Freynhofer MK; Bruno V; Wojta J; Huber K
Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
